RT Journal Article
SR Electronic
T1 HIP1 mediates oncogenic transformation and cancer progression through STAT3 signalling
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 2020.07.09.191734
DO 10.1101/2020.07.09.191734
A1 Roheet Bantval Rao
A1 Antonio Ramos-Montoya
A1 Helen Scott
A1 Lorraine Berry
A1 Stefanie Reichelt
A1 Stewart MacArthur
A1 Roslin Russell
A1 David E Neal
A1 Emma Evergren
A1 Ian G Mills
YR 2020
UL http://biorxiv.org/content/early/2020/07/09/2020.07.09.191734.abstract
AB Background Huntingtin-interacting protein 1 (HIP1) is an adaptor protein involved in transcriptional regulation and receptor-mediated endocytosis. Overexpression of HIP1 transforms cell and is associated with, increasing grades of prostate cancer (CaP) and poor patient outcomes. However, the precise mechanism for the role of HIP1 in prostate cancer progression remains unknown.Methods Using a phospho-kinase antibody array we identified changes in signalling associated with HIP1 overexpression PNT1 cells. For validation Western blots were used together with knockdown or inhibitor treatments and phenotypic assays for cellular transformation. The cell line was xenografted to assess tumour growth. Gene expression microarray analysis of the cell line was used to identify perturbations in transcript levels.Results Here we demonstrate cellular transformation and phenotypic effects of HIP1 overexpression in a benign prostate epithelial cell line to be dependent on STAT3 signalling. In vivo xenografts confirmed the cellular transformation phenotype. Gene expression analysis revealed serum protein GDF15 to be a marker of prostate cancer tumorigenesis in our model. We present a HIP1-STAT3-GDF15 axis in our pre-clinical model that mediates cellular transformation and tumorigenesis.Conclusion Our findings provide a model defining the functional effects of increased HIP1 expression in prostate tumorigenesis and progression. This model implicates increased STAT3 signalling in HIP1-dependent prostate carcinogenesis and identifies GDF15 as a secreted factor supporting this process. The role of HIP1-STAT3-GDF15 signalling may extend to other epithelial cancers shown to overexpress HIP1; such as gliomas, colon and breast cancer where STAT3 is an emerging oncology drug target.Competing Interest StatementThe authors have declared no competing interest.HIP1Huntingtin-interacting protein 1CaPprostate cancerSTAT3Signal transducer and activator of transcription 3kDakilo DaltonFGFfibroblast growth factorFGFRfibroblast growth factor receptorGDF15Growth Differentiation Factor 15ARandrogen receptorGFPgreen fluorescent proteinHRPhorse radish peroxidaseqRT-PCRquantitative real time polymerase chain reactionGAPDHGlyceraldehyde 3-phosphate dehydrogenaseEVempty vectorshRNAshort hairpin ribonucleic acidRPMIRoswell Park Memorial InstituteFCSfoetal calf serummRNAmessenger ribonucleic acidsiRNASmall interfering ribonucleic acidPMSFPhenylmethanesulfonyl fluoridDTTDithiothreitolEDTAEthylenedinitrilotetraacetic acidSDS-PAGEsodium dodecyl sulfate-polyacrylamide gel electrophoresisPVDFPolyvinylidene difluorideRFUrelative fluorescence unitAMPK1αProtein kinase AMP-activated catalytic subunit alpha 1PLC-γ1Phospholipase C-γ1MEK1Mitogen-activated protein kinase kinase 1JAK2Janus kinase 2DMSODimethyl sulfoxideERK1/2extracellular signal-regulated protein kinase ½DEGdifferentially expressed geneTGF-betatransforming growth factor-betaELISAenzyme-linked immunosorbent assayIgGImmunoglobulin GRTKsreceptor tyrosine kinasesEGFRepidermal growth factor receptorISGF3Interferon stimulated gene factor 3IRF9Interferon regulatory factor 9DNMT1DNA (cytosine-5)-methyltransferase 1HDACHistone deacetylaseSTINGstimulator of interferon genesGFRALGlial cell-derived neurotrophic factor Family Receptor Alpha LikeRETrearranged during transfectionCFLARCASP8 and FADD-Like Apoptosis Regulator